Career history of Robert Whalen
Former positions of Robert Whalen
| Companies | Position | Start | End |
|---|---|---|---|
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | - | - |
Altravax, Inc.
 Altravax, Inc. Pharmaceuticals: MajorHealth Technology Altravax, Inc. discovers and develops new vaccines to fight infectious diseases. The firm’s proprietary technologies offer unique opportunities to create novel vaccine or improve currently available alternatives to fill unmet medical needs. It provides contract services. It has a robust pipeline of candidates at various stages of development. The company was founded by Sean X. Du and Robert Whalen in 2009 and is headquartered in Sunnyvale, CA. | Director/Board Member | 2008-12-31 | - |
| Chief Tech/Sci/R&D Officer | 2011-05-18 | - | |
| Founder | 2011-05-18 | - |
Training of Robert Whalen
| Harvard University | Graduate Degree |
| The Pennsylvania State University | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Altravax, Inc.
Altravax, Inc. Pharmaceuticals: MajorHealth Technology Altravax, Inc. discovers and develops new vaccines to fight infectious diseases. The firm’s proprietary technologies offer unique opportunities to create novel vaccine or improve currently available alternatives to fill unmet medical needs. It provides contract services. It has a robust pipeline of candidates at various stages of development. The company was founded by Sean X. Du and Robert Whalen in 2009 and is headquartered in Sunnyvale, CA. | Health Technology |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
- Stock Market
- Insiders
- Robert Whalen
- Experience
